Journals / Kulak Burun Boğaz Klinikleri / 2003 / Cilt: 5 - Sayı: 3

Therapeutic use of Botulinum toxin A in a patient with Frey syndrome

Frey sendromlu bir olguda Botulinum toksin A uygulaması

Pages
158–160
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Three weeks after the second injection, the Minor's test showed complete disappearance of the sweating areas.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:A twenty-seven-year-old female patient who had undergone superficial parptidectomy for pleomorphic adenoma developed Frey's syndrome eight months after surgery.
📊
Key Findings & Data:Botulinum toxin type A (2.5 U/cm2) was injected intradermally to the affected sites.
💡
Conclusion & Impact:Three weeks after the second injection, the Minor's test showed complete disappearance of the sweating areas.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Botulinum toksini tip A · Terleme · gustatuar

Abstract

A twenty-seven-year-old female patient who had undergone superficial parptidectomy for pleomorphic adenoma developed Frey's syndrome eight months after surgery. The diagnosis was confirmed with the use of the Minor's iodine-starch test. Botulinum toxin type A (2.5 U/cm2) was injected intradermally to the affected sites. Her symptoms disappeared two days after the injection and repeat Minor's test performed after three weeks showed a dramatic decrease in the sweating areas. However, her symptoms recurred eight months after the injection and the Minor's test revealed areas of sweating. Botulinum toxin A was injected once more at the same dose. Three weeks after the second injection, the Minor's test showed complete disappearance of the sweating areas.

Özet

Pleomorfik adenom nedeniyle yüzeyel parotidektomi uygulanan 27 yaşındaki kadın hastada ameliyattan sekiz ay sonra Frey sendromu gelişti. Minör testi ile tanısı kesinleştirilen hastaya intrakutan olarak 2.5 U/cm2 botulinum toksin A infiltrasyonu yapıldı. Enjeksiyondan iki gün sonra semptomların tamamına yakınının kaybolduğu; üç hafta sonra yapılan Minör testinde terleme alanlarının neredeyse tümüyle kaybolduğu gözlendi. Hastanın semptomlarının sekiz ay sonra tekrarlaması üzerine yapılan Minör testinde Frey sendromunun nüks ettiği görüldü. Botulinum toksin A enjeksiyonu aynı dozda tekrarlandı. Üç hafta sonraki Minör testi terleme alanlarının tamamen kaybolduğunu gösterdi.

🔖

Cite This Article

DEREKÖYLÜ, L., KARAKULLUKÇU, M. B., YÜKSEL, S., ÖZDOĞAN, A. (2003). Therapeutic use of Botulinum toxin A in a patient with Frey syndrome. Kulak Burun Boğaz Klinikleri, Cilt: 5 - Sayı: 3, 158–160. https://ajindex.com/articles/343348

References (8)

  1. Dulguerov P, Quinodoz D, Cosendai G, Piletta P, Lehmann W. Frey syndrome treatment with botu¬ linum toxin. Otolaryngol Head Neck Surg 2000; 122:821-7
  2. Von Lindern JJ, Niederhagen B, Berge S, Hagler G, Reich RH. Frey syndrome: treatment with type A botulinum toxin. Cancer 2000;89:1659-63
  3. Birch JF, Varma SK, Narula AA. Botulinum toxoid in the management of gustatory sweating (Frey's syn- drome) after superficial parotidectomy. Br J Plast Surg 1999;52:230-l
  4. Dulguerov P, Quinodoz D, Cosendai G, Piletta P, Marchal F, Lehmann W. Prevention of Frey syn- drome during parotidectomy. Arch Otolaryngol Head Neck Surg 1999;125:833-9
  5. Drobik C, Laskawi R. Frey's syndrome: treatment with botulinum toxin. Acta Otolaryngol 1995;115: 459-61
  6. Laccourreye O, Muscatelo L, Naude C, Bonan B, Brasnu D. Botulinum toxin type A for Frey's syn- drome: a preliminary prospective study. Ann Otol Rhinol Laryngol 1998;107:52-5
  7. Laskawi R, Drobik C, Schonebeck C. Up-to-date report of botulinum toxin type A treatment in patients with gustatory sweating (Frey's syndrome). Laryngoscope 1998;108:381-4
  8. Bjerkhoel A, Trobbe O. Frey's syndrome: treatment with botulinum toxin. J Laryngol Otol 1997;111: 839-44.